2.615

0.57% -0.015

Cronos Group Inc (CRON)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.63

Aprire:

$2.63

Volume 24 ore:

260.93K

Relative Volume:

0.18

Capitalizzazione di mercato:

$977.13M

Reddito:

$146.59M

Utile/perdita netta:

$-2.93M

Rapporto P/E:

-107.17

EPS:

-0.0244

Flusso di cassa netto:

$-190.40K

1 W Prestazione:

-4.91%

1M Prestazione:

-2.79%

6M Prestazione:

+7.17%

1 anno Prestazione:

+22.20%

Intervallo 1D:

$2.60

$2.65

Intervallo di 1 settimana:

$2.56

$2.82

Portata 52W:

$1.84

$3.43

Cronos Group Inc Stock (CRON) Company Profile

Nome

Cronos Group Inc

Settore

Healthcare (1105)

Industria

Drug Manufacturers - Specialty & Generic (84)

Telefono

(416) 504-0004

Indirizzo

4491 CONCESSION RD 12, STAYNER, ON

Dipendente

610

Cinguettio

@cronosgroup

Prossima data di guadagno

2026-05-11

Ultimi documenti SEC

CRON's Discussions on Twitter

Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRON Cronos Group Inc	2.615	982.73M	146.59M	-2.93M	-190.40K	-0.0244
TAK Takeda Pharmaceutical Co Adr	16.66	52.48B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.1201	39.72B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.20	39.93B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.62	31.12B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	565.27	24.13B	3.17B	1.29B	1.01B	27.09

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-27	Iniziato	Canaccord Genuity	Buy
2022-11-02	Iniziato	Bernstein	Mkt Perform
2022-07-28	Aggiornamento	Canaccord Genuity	Hold → Buy
2022-05-11	Aggiornamento	CIBC	Neutral → Sector Outperform
2022-03-22	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-27	Aggiornamento	Jefferies	Underperform → Hold
2021-11-18	Ripresa	BofA Securities	Underperform
2021-04-28	Ripresa	BofA Securities	Underperform
2021-02-22	Downgrade	CIBC	Sector Outperform → Neutral
2020-06-24	Aggiornamento	Raymond James	Mkt Perform → Outperform
2020-04-27	Downgrade	Raymond James	Outperform → Mkt Perform
2020-04-14	Downgrade	Piper Sandler	Overweight → Neutral
2020-04-02	Downgrade	BofA/Merrill	Buy → Neutral
2020-03-31	Downgrade	Canaccord Genuity	Hold → Sell
2020-03-04	Aggiornamento	MKM Partners	Neutral → Buy
2020-03-03	Downgrade	Stifel	Buy → Hold
2019-10-18	Aggiornamento	Stifel	Hold → Buy
2019-09-20	Iniziato	MKM Partners	Neutral
2019-09-05	Aggiornamento	BMO Capital Markets	Underperform → Market Perform
2019-08-13	Iniziato	Piper Jaffray	Overweight
2019-08-09	Aggiornamento	Canaccord Genuity	Sell → Hold
2019-06-28	Iniziato	Consumer Edge Research	Equal Weight
2019-06-06	Iniziato	Stifel	Hold
2019-06-05	Aggiornamento	BofA/Merrill	Underperform → Buy
2019-04-17	Iniziato	BofA/Merrill	Underperform
2019-03-27	Downgrade	Canaccord Genuity	Hold → Sell
2019-02-25	Iniziato	Jefferies	Underperform
2019-01-18	Iniziato	CIBC	Sector Outperform

Mostra tutto

Cronos Group Inc Borsa (CRON) Ultime notizie

10:03 AM

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

10:03 AM

01:08 AM

Cronos Expands Spinach STIX Pre Rolls And Chases Canadian Market Share - Yahoo Finance

01:08 AM

May 17, 2026

Cronos Group stock (CA22717L1013): cannabis player shifts focus as Q1 loss widens - AD HOC NEWS

May 17, 2026

May 16, 2026

Cronos targets Canadelaar close in summer 2026 while renewing $50M buyback - MSN

May 16, 2026

Cronos: Strong Q1 Earnings Driven By International Cannabis Sales - Seeking Alpha

May 14, 2026

Cronos Group (CRON) officer exercises 10,597 RSUs, with 5,199 shares for tax - Stock Titan

May 14, 2026

Cronos Group (CRON) officer receives 10,367 shares as RSUs vest - Stock Titan

May 14, 2026

Cronos Group (CRON) officer exercises RSUs and withholds shares to cover taxes - Stock Titan

May 14, 2026

Cronos Group (CRON) officer settles RSUs and tax withholding shares - Stock Titan

May 14, 2026

May 13, 2026

Cronos Group Inc. stock falls Wednesday, underperforms market - MarketWatch

May 13, 2026

Short-Seller Left Didn’t Make ‘Sense,’ Cronos CEO Testifies - Bloomberg.com

May 13, 2026

Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade) (NASDAQ:CRON) - Seeking Alpha

May 13, 2026

Cronos Group stock (CA22717L1013): Q1 revenue hits record $45.2M amid rescheduling boost - AD HOC NEWS

May 13, 2026

Cronos Group (CRON) Q1 earnings meet estimates - MSN

May 13, 2026

May 12, 2026

Short-Seller Left ‘Didn’t Make Much Sense,’ Cronos CEO Testifies - Bloomberg.com

May 12, 2026

Cronos Group (CRON) executive converts 3,118 RSUs into common shares, holding 211,555 shares - Stock Titan

May 12, 2026

Cronos Group (NASDAQ: CRON) officer converts RSUs into 20,470 common shares - Stock Titan

May 12, 2026

Cronos Group (CRON) officer exercises RSUs, uses 4,774 shares for taxes - Stock Titan

May 12, 2026

TD Cowen Maintains Cronos Group(CRON.US) With Buy Rating, Raises Target Price to $4.02 - Moomoo

May 12, 2026

Cronos Group Reports 2026 First Quarter Results - Sahm

May 12, 2026

Cronos Group Announces New Share Buyback After Strong Quarter - The Globe and Mail

May 12, 2026